LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy

BACKGROUND: Low molecular weight protein tyrosine phosphatase (LMW-PTP) is overexpressed in different cancer types and its expression is related to more aggressive disease, reduced survival rate and drug resistance. Morin is a natural polyphenol which negatively modulates, among others, the activity...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Cell Int
Autors principals: Capitani, Nagaja, Lori, Giulia, Paoli, Paolo, Patrussi, Laura, Troilo, Arianna, Baldari, Cosima T., Raugei, Giovanni, D’Elios, Mario Milco
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Primary Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6429822/
https://ncbi.nlm.nih.gov/pubmed/30948927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0786-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars